颅底脑膜瘤术前栓塞后早期体积反应与瘤内对比增强丢失的关联
回顾性纳入82例颅底脑膜瘤患者,术前栓塞后平均4.1天复查MRI,肿瘤体积平均缩小10.5%,90.2%患者体积下降,且瘤内对比增强丢失越明显体积缩小率越大,提示增强丢失可作为反映栓塞后血供减少的半定量影像指标。
要点
- 术前栓塞后数天内即可见颅底脑膜瘤体积缩小,平均缩小率约10.5%。
- 栓塞后MRI瘤内对比增强丢失程度与体积缩小率正相关。
- 体积反应个体差异大,缩小率范围-34.5%至41.1%,需个体化评估。
关键影像表现/征象
- 栓塞后肿瘤体积显著缩小(18.9 ± 14.2 mL vs 17.3 ± 13.7 mL,P < .001),平均缩小率10.5 ± 12.4%,平均间隔4.1 ± 1.8天。
- 82例中74例(90.2%)肿瘤体积下降,体积反应异质性大,范围-34.5%至41.1%。
- 瘤内对比增强丢失越明显,体积缩小率越大(P = .04)。
诊断标准与关键数值
- 按栓塞后MRI瘤内对比增强丢失程度将患者分为四组,用于分析体积反应与增强丢失的关联。
临床应用与阅片要点
- 栓塞后复查MRI时关注瘤内对比增强丢失程度,可辅助判断栓塞后血供减少及早期体积反应。
- 报告可描述肿瘤体积变化及增强丢失情况,但需注意体积反应个体差异大,不能仅凭体积变化判断栓塞效果。
局限性
- 单中心回顾性设计,样本量有限,结论需多中心验证。
- 栓塞后MRI复查间隔较短且存在个体差异,可能影响体积测量的一致性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
英文原文(摘要)· 点击展开
OBJECTIVE: The role of preoperative embolization for skull base meningiomas remains controversial because potential surgical benefits must be balanced against endovascular procedural risks. Although embolization may induce early tumor volume reduction, evidence in skull base meningiomas remains limited. This study evaluated prompt volumetric responses after preoperative embolization and their association with intratumoral contrast enhancement loss on magnetic resonance imaging (MRI).
METHODS: This retrospective study included 82 consecutive patients with skull base meningiomas who underwent preoperative endovascular embolization followed by surgical resection at a single institution between September 2013 and March 2025. Tumor volumes were measured on contrast-enhanced T1-weighted MRI obtained pre- and post-embolization. Individual volumetric responses were evaluated, and patients were categorized into four groups according to the degree of intratumoral contrast enhancement loss. Neurological complications were assessed.
RESULTS: Tumor volume was significantly reduced after embolization (18.9 ± 14.2 mL vs 17.3 ± 13.7 mL, P < .001), with a mean reduction rate of 10.5 ± 12.4%, within a mean interval of 4.1 ± 1.8 days after embolization. Tumor volume decreased in 74 of 82 patients (90.2%). Volumetric responses exhibited substantial heterogeneity, ranging from -34.5% to 41.1%. Greater intratumoral contrast enhancement loss was associated with larger volume reduction rates (P = .04). Transient neurological complications occurred in 4 patients (4.9%), and permanent deficits occurred in 2 patients (2.4%).
CONCLUSIONS: Preoperative embolization of skull base meningiomas was associated with early tumor volume reduction within days, although the magnitude of response varied substantially among tumors. Intratumoral contrast enhancement loss on post-embolization MRI was associated with greater tumor volume reduction and may serve as a semiquantitative imaging correlate of reduced tumor vascularity/perfusion after embolization.
引用
- Sakamoto H, Hashimoto T, Matsushima K, et al. Prompt volumetric responses following preoperative embolization of skull base meningiomas: association with intratumoral contrast enhancement loss. AJNR Am J Neuroradiol. 2026. PMID: 42827002. doi:10.3174/ajnr.A9661
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。